PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progressionPeey‐Sei Kok, Rachel O’Connell, Peter Grant et al.|Journal of Gynecologic Oncology|2019Cited by 26